SLARD 2026: Effects of Preemptive Gabapentin With Multimodal Analgesia vs Analgesia Alone in TKA .
OrthoEvidence Journal (OE Journal) - ACE Report
Epub Ahead of Print
6 randomized controlled trials involving 472 patients undergoing total knee arthroplasty (TKA) compared preemptive gabapentin combined with multimodal analgesia vs multimodal analgesia alone or placebo. The pooled outcomes of interest included postoperative pain, opioid consumption, adverse effects, length of hospital stay, range of motion, and inflammatory markers. The meta-analysis demonstrated no significant differences in pain scores or opioid consumption within 24 hours after surgery between groups. Although minor improvements in nausea, pruritus, and early range of motion were observed, these effects were transient and not clinically meaningful. Overall, the findings suggest that adding preemptive gabapentin to multimodal analgesia does not provide significant clinical benefits after TKA and is not supported for routine use based on the current evidence.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!